IL17A and vasculitis: Furthermore, in general, Th17 cells are resistant to glucocorticoid-induced apoptosis (21), suggesting that activated IL-17 signalling is potentially resistant to conventional immunosuppressive therapy including glucocorticoids, leading to persistent vasculitis accompanying frequent relapses in a part of LVV patients with IL-17 activated signature.